Covered recipient · General Payments record
KELLY FISK
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,217.42
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $224.89 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $76.39 | 3 |
| Gilead Sciences, Inc. | $62.62 | 3 |
| Braeburn Inc. | $31.33 | 2 |
| Otsuka America Pharmaceutical, Inc. | $19.79 | 1 |
| ITI, Inc. | $17.69 | 1 |
| Orexo US, Inc. | $17.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Braeburn Inc. | $17.70 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125616432 | CMS |
| Braeburn Inc. | $13.63 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125616434 | CMS |
| Gilead Sciences, Inc. | $13.51 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133726809 | CMS |
| Gilead Sciences, Inc. | $24.62 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133726811 | CMS |
| Gilead Sciences, Inc. | $24.49 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133726813 | CMS |
| Indivior Inc. | $32.79 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552014 | CMS |
| Indivior Inc. | $20.40 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552016 | CMS |
| Indivior Inc. | $23.20 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552018 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.69 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143448268 | CMS |
| Orexo US, Inc. | $17.07 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136176657 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.79 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119071294 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.